New drug trial offers hope for severe eczema sufferers

NCT ID NCT07277660

Summary

This study is testing an investigational drug called galvokimig for adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare different doses of the drug against a placebo to see which works best at reducing skin inflammation and itching. The trial will enroll 160 participants and track their progress over 16 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Atd002 21004

    RECRUITING

    Tachikawa-shi, Japan

  • Atd002 21005

    RECRUITING

    Sakai, Japan

  • Atd002 21008

    RECRUITING

    Sapporo, Japan

  • Atd002 51006

    RECRUITING

    Hamilton, Canada

  • Atd002 51007

    RECRUITING

    Toronto, Canada

  • Atd002 52001

    RECRUITING

    Troy, Michigan, 48084, United States

  • Atd002 52003

    RECRUITING

    Miami, Florida, 33133, United States

  • Atd002 52004

    RECRUITING

    Sugar Land, Texas, 77479, United States

  • Atd002 52005

    RECRUITING

    Dallas, Texas, 75230, United States

  • Atd002 52007

    RECRUITING

    Coral Gables, Florida, 33134, United States

  • Atd002 52008

    RECRUITING

    Santa Monica, California, 90404, United States

  • Atd002 52009

    RECRUITING

    Troy, Michigan, 48084, United States

  • Atd002 52010

    RECRUITING

    Omaha, Nebraska, 68144, United States

  • Atd002 52011

    RECRUITING

    Frisco, Texas, 75034, United States

  • Atd002 52012

    RECRUITING

    New Albany, Indiana, 47150, United States

  • Atd002 52013

    RECRUITING

    Boca Raton, Florida, 33486, United States

  • Atd002 52014

    RECRUITING

    Bowling Green, Kentucky, 42104, United States

  • Atd002 52015

    RECRUITING

    Savannah, Georgia, 31419, United States

  • Atd002 52016

    RECRUITING

    Frisco, Texas, 75033, United States

  • Atd002 52017

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Atd002 52018

    RECRUITING

    Wheaton, Illinois, 60189, United States

  • Atd002 52019

    RECRUITING

    Philadelphia, Pennsylvania, 19114, United States

  • Atd002 52020

    RECRUITING

    The Bronx, New York, 10455, United States

Conditions

Explore the condition pages connected to this study.